Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Long-Term-Debt" stands at 39.41 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Johnson & Johnson's third quarter, the item "Long Term Debt" stands at 39.41 Billion USD. This represents an increase of 0.44 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 25.95 percent compared to the value the year prior.
The 1 year change in percent is 25.95.
The 3 year change in percent is 42.77.
The 5 year change in percent is 20.59.
The 10 year change in percent is 180.03.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Long Term Debt | 905,699,262,464.00 |
![]() | AbbVie Inc - Long Term Debt | 399,570,305,024.00 |
![]() | Roche Holding AG - Long Term Debt | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Long Term Debt | 280,205,508,085.11 |
![]() | Novartis AG - Long Term Debt | 255,096,620,580.91 |